Inventor · disambiguated record
Christoph-Stephan Hilger
Also filed as: HILGER CHRISTOPH · HILGER CHRISTOPH-STEPHAN
26 granted patents·19 pending applications·713 citations·filing 1993–2024
96Inventor score
Top patents by PatentIndex Score
45 records- 0198US7445767B2In-vivo diagnostic method by near infrared radiationDIAGNOSTIKFORSCHUNG INST·Filed 2006·Granted Nov 4, 2008·53 cites·2 claims
- 0298US6258340B1In-vivo diagnostic method by near infrared radiationDIAGNOSTIKFORSCHUNG INST·Filed 2000·Granted Jul 10, 2001·157 cites·3 claims
- 0398US6083485ANear infrared radiation in-vivo diagnostic methods and dyesDIAGNOSTIKFORSCHUNG INST·Filed 1995·Granted Jul 4, 2000·236 cites·7 claims
- 0496US7025949B2In-vivo diagnostic method by means of near infrared radiationDIAGNOSTIKFORSCHUNG INST·Filed 2001·Granted Apr 11, 2006·48 cites·4 claims
- 0596US6926885B2In-vivo diagnostic method by means of near infrared radiationUNIV BERLIN FREIE·Filed 2002·Granted Aug 9, 2005·56 cites·3 claims
- 0696US6913743B2Near infrared imaging agentDIAGNOSTIKFORSCHUNG INST·Filed 2003·Granted Jul 5, 2005·56 cites·11 claims
- 0795US7655217B2Near infrared imaging agentINST DIAGNOSIKFORSCHUNG GMBH·Filed 2006·Granted Feb 2, 2010·35 cites·3 claims
- 0893US12478696B2Gadolinium chelate compounds for use in magnetic resonance imagingBayer Pharma AG·Filed 2024·Granted Nov 25, 2025·1 cites·14 claims
- 0991US11491245B2Gadolinium chelate compounds for use in magnetic resonance imagingBayer Pharma AG·Filed 2020·Granted Nov 8, 2022·2 cites·12 claims
- 1088US10722601B2Gadolinium chelate compounds for use in magnetic resonance imagingBayer Pharma AG·Filed 2018·Granted Jul 28, 2020·2 cites·16 claims
- 1184US10137209B2Gadolinium chelate compounds for use in magnetic resonance imagingBayer Pharma AG·Filed 2016·Granted Nov 27, 2018·2 cites·13 claims
- 1282US5849259A3-,8-substituted deuteroporphyrin derivatives, pharmaceutical agents containing the latter and process for their productionDIAGNOSTIKFORSCHUNG INST·Filed 1993·Granted Dec 15, 1998·26 cites·14 claims
- 1379US2023113481A1New gadolinium chelate compounds for use in magnetic resonance imagingBayer Pharma AG·Filed 2022·Application pending·0 cites
- 1476US10975060B2High relaxivity gadolinium chelate compounds for use in magnetic resonance imagingBayer Pharma AG·Filed 2017·Granted Apr 13, 2021·1 cites·13 claims
- 1575US9278925B2Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-oneLIU NINGSHU·Filed 2012·Granted Mar 8, 2016·3 cites·8 claims
- 1675US6676926B2Radiopharmaceuticals for diagnosing Alzheimer's diseaseSCHERING AG·Filed 2001·Granted Jan 13, 2004·10 cites·37 claims
- 1773US9000026B2Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapyLIU NINGSHU·Filed 2012·Granted Apr 7, 2015·2 cites·7 claims
- 1869US6709693B1Stents with a radioactive surface coating, processes for their production and their use for restenosis prophylaxisSCHERING AG·Filed 2000·Granted Mar 23, 2004·16 cites·10 claims
- 1968US2005106106A1In-vivo diagnostic method by near infrared radiationDIAGNOSTIKFORSCHUNG INST·Filed 2004·Application pending·0 cites
- 2065US11814369B2High relaxivity gadolinium chelate compounds for use in magnetic resonance imagingBayer Pharma AG·Filed 2021·Granted Nov 14, 2023·0 cites·11 claims
- 2163US2010129293A1Near Infrared Imaging AgentDIAGNOSTIKFORSCHUNG INST·Filed 2010·Application pending·0 cites
- 2261US2016046604A1Heteroaryl substituted indazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2359US6872381B1Radiopharmaceuticals for diagnosing Alzheimer's diseaseSCHERING AG·Filed 2003·Granted Mar 29, 2005·1 cites·30 claims
- 2459US2016052912A1Diaminoheteroaryl substituted indazolesBAYER PHARMA AKITIENGESELLSCHAFT·Filed 2014·Application pending·0 cites
- 2555US2005169844A1Near infrared imaging agentDIAGNOSTIKFORSCHUNG INST·Filed 2005·Application pending·0 cites
- 2654US9212140B2(5s,8s)-3-(4′-chlor-3′-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5] dec-3-en-2-one (compound A) for treatmentLIU NINGSHU·Filed 2012·Granted Dec 15, 2015·0 cites·2 claims
- 2753US2017275267A1Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancerBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2851US2017283396A1Diaminoheteroaryl substituted indazolesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2950US8491906B2Selective targeting of tumor vasculature using antibody moleculesBORSI LAURA·Filed 2003·Granted Jul 23, 2013·1 cites·13 claims
- 3048US2015141372A1Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancerBayer Pharma AG·Filed 2013·Application pending·0 cites
- 3147US2009214423A1Selective targeting of tumor vasculature using radiolabelled antibody moleculesBORSI LAURA·Filed 2009·Application pending·0 cites
- 3247US2007032694A1Stents with a radioactive surface coating, processes for their production and their use for restenosis prophylaxisDINKELBORG LUDGER·Filed 2003·Application pending·0 cites
- 3346US2004001790A1Methods for diagnosis and treatment of tumoursSCHERING AG·Filed 2003·Application pending·0 cites
- 3445US2005074401A1Selective targeting of tumor vasculature using radiolabelled antibody moleculesFiled 2004·Application pending·0 cites
- 3545US2017275268A1Heteroaryl substituted indazolesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 3644US2004258620A1(Ethylene)-( propylene)-triaminepentaacetic acid derivatives, process for their production, and their use for the production of pharmaceutical agentsFiled 2002·Application pending·0 cites
- 3740US2003194371A1(Ethylene)-(propylene) - triaminepentaacetic acid derivatives, process for their production, and their use for the production of pharmaceutical agentsSCHERING AG·Filed 2002·Application pending·0 cites
- 3839US2003119719A1Use of endothelin conjugates in therapy, new endothelin conjugates, agents that contain the latter, and process for their productionFiled 2001·Application pending·0 cites
- 3937US2013040935A1Cyclic keto-enols for therapyBAYER IP GMBH·Filed 2011·Application pending·0 cites
- 4035US6749896B2Self-cross linking powder paint based on epoxy resins and the use thereofBASF COATINGS AG·Filed 2001·Granted Jun 15, 2004·0 cites·10 claims
- 4134US6342201B1Complex compounds for diagnosis of vascular diseasesDIAGNOSTIKFORSCHUNG INST·Filed 1995·Granted Jan 29, 2002·1 cites·15 claims
- 4230US6242052B1Triboelectric chargeable coating powderBASF COATINGS AG·Filed 1998·Granted Jun 5, 2001·3 cites·15 claims
- 4330US2002077306A1Conjugates made of metal complexes and oligonucleotides, agents containing the conjugates, their use in radiodiagnosis as well as process for their productionFiled 1995·Application pending·0 cites
- 4427US5961954AChealators of type XN1 S1 X1 for radioactive isotopes, their metal complexes and their diagnostic and therapeutical usesDIAGNOSTIKFORSCHUNG INST·Filed 1994·Granted Oct 5, 1999·1 cites·36 claims
- 4526US6143275AType S3 N2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical useDIAGNOSTIKFORSCHUNG INST·Filed 1994·Granted Nov 7, 2000·0 cites·36 claims
Join the waitlist — get patent alerts
Get an alert when Christoph-Stephan Hilger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →